(P) PRIMER: Restricțiile de energie în fabricile de medicamente pot afecta accesul pacienților

The Romanian Pharmaceutical Manufacturers Association (PRIMER) urges the government to classify drug manufacturers as strategic energy consumers to ensure continuous electricity supply. This is crucial for maintaining the production of essential medications. Interruptions in power supply can disrupt manufacturing processes, leading to significant losses and delays in drug availability. Given the current shortages and reliance on imports, any impact on local production could worsen supply issues for hospitals and pharmacies. PRIMER emphasizes the need for collaboration with the government to address energy challenges without compromising public health and access to treatments.